Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology

被引:86
|
作者
Eikenboom, JCJ [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Haematol, Haemostasis & Thrombosis Res Ctr, NL-2300 RC Leiden, Netherlands
关键词
von Willebrand disease; von Willebrand factor; drug therapy; antibodies; factor VIII; congenital; genetics; mutation;
D O I
10.1053/beha.2001.0139
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand disease type 3 is the most severe form of this condition. Patients present with a moderate-to-severe bleeding tendency. The plasma von Willebrand factor level in these patients is very low or undetectable. Although rare, von Willebrand disease type 3 is of major interest because of its severe clinical presentation, the need for replacement therapy and the risk of occurrence of alloantibodies after the infusion of plasma concentrates. The inheritance of type 3 disease is typically autosomal recessive. The parents are often consanguineous, although compound heterozygous inheritance does occur. The molecular basis of von Willebrand disease type 3 has recently been studied in detail, several molecular defects being identified. This chapter will focus on the clinical and molecular aspects of type 3 von Willebrand disease.
引用
收藏
页码:365 / 379
页数:15
相关论文
共 50 条
  • [21] von Willebrand disease: Recent advances in pathophysiology and treatment
    Phillips, MD
    Santhouse, A
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1998, 316 (02) : 77 - 86
  • [22] Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance
    Castaman, G.
    Tosetto, A.
    Rodeghiero, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 71 - 74
  • [23] Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: Diagnostic and therapeutic implications
    Michiels, JJ
    van de Velde, A
    van Vliet, HHDM
    van der Planken, M
    Schroyens, W
    Berneman, Z
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (02) : 111 - 131
  • [24] The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease
    Flood, Veronica H.
    Garcia, Jessica
    Haberichter, Sandra L.
    CURRENT OPINION IN HEMATOLOGY, 2019, 26 (05) : 331 - 335
  • [25] Platelet-Type von Willebrand Disease: New Insights into the Molecular Pathophysiology of a Unique Platelet Defect
    Othman, Maha
    Kaur, Harmanpreet
    Emsley, Jonas
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2013, 39 (06) : 663 - 673
  • [26] Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
    Simon, D
    Bandinelli, E
    Roisenberg, I
    GENETICS AND MOLECULAR BIOLOGY, 2003, 26 (04) : 397 - 401
  • [27] The molecular characterization of von Willebrand disease: good in parts
    James, P. D.
    Lillicrap, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (02) : 166 - 176
  • [28] Molecular genetics of type 2 von Willebrand disease
    Fressinaud, E
    Mazurier, C
    Meyer, D
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 75 (01) : 9 - 18
  • [29] Molecular Genetics of Type 2 von Willebrand Disease
    Edith Fressinaud
    Claudine Mazurier
    Dominique Meyer
    International Journal of Hematology, 2002, 75 : 9 - 18
  • [30] Type 1 von Willebrand disease
    Peake, I.
    Goodeve, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 : 7 - 11